BioSpace News Archive

Business

Nordic Nanovector ASA: Allocation of Restricted Stock Unites (RSUs) to the Board of Directors - July 01, 2020

Reference is made to the minutes from Nordic Nanovector ASA’s annual general meeting held on 10 June 2020 in Oslo, Norway.

July 1, 2020
·
3 min read
Business

Lysogene Announces a Research Collaboration With the Weizmann Institute of Science

Lysogene, a Phase 3 gene therapy platform company targeting central nervous system diseases, announced that the company has entered into a collaborative research agreement with Yeda Research and Development Co Ltd, the commercial arm of the Weizmann Institute of Science.

July 1, 2020
·
4 min read
Policy

Carag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder With Bioresorbable, Metal-free Framework

CARAG AG, a privately-held Swiss medical device development company, announced receiving U.S. Food and Drug Administration Investigational Device Exemption approval for its Carag Bioresorbable Septal Occluder.

July 1, 2020
·
4 min read
Business

Invitation to Presentation of BioArctic’s Interim Report for the Period January - June 2020 on July 10 at 9.30 a.m. CET

BioArctic AB to publish the company’s Interim Report for the period January - June 2020 on Friday, July 1, 2020, at 08:00 a.m. CET.

July 1, 2020
·
2 min read
Business

Mentice Appoints Thanos Karras as Americas General Manager to Accelerate Group’s Growth Strategy

Mentice AB announced the appointment of Thanos Karras as the company’s new General Manager for Americas.

July 1, 2020
·
2 min read
Business

Dr. Reddy’s Partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a Potential Treatment of COVID-19

Dr. Reddy’s Laboratories Ltd. announces partnering with FUJIFILM Corporation through FUJIFILM Toyama Chemical Co. Ltd. and Global Response Aid for the development, manufacture and sales of Avigan® Tablets, a potential treatment of COVID-19.

July 1, 2020
·
6 min read
Business

BioInvent Extends Research Collaboration and License Agreement With Pfizer Inc.

BioInvent International AB announces that it has further extended the research term under its cancer immunotherapy research collaboration and license agreement with Pfizer Inc. until the end of 2020.

July 1, 2020
·
3 min read
BioMidwest

Luminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research Partners

Luminex Corporation announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its Life Science Research Partners, achieving a major milestone in the company’s strategy to extend its xMAP Technology with new functionality to facilitate new applications.

July 1, 2020
·
5 min read
Business

AM-Pharma Announces the Appointment of Rita Jain M.D. to its Supervisory Board

AM-Pharma B.V., an emerging leader focused on the treatment of acute kidney injury, announced the appointment of Rita Jain, M.D., to the Company’s Supervisory Board.

July 1, 2020
·
3 min read
Deals

Sectra Publishes Annual Report, Sustainability Report and Corporate Governance Report for 2019/2020

International medical imaging IT and cybersecurity company Sectra publishes its Annual Report and Sustainability Report for the 2019/2020 financial year as well as the Board of Directors’ Corporate Governance Report for the corresponding period.

July 1, 2020
·
2 min read